Lipfendra is the first oral PCSK9 inhibitor approved to lower LDL cholesterol. In clinical trials, Lipfendra lowered LDL cholesterol by about 56%-59% for patients who were already taking statins.
The Mississippi medical examiner tells TMZ ... the autopsy they performed on July 7 was "in accordance with the standard ...
Health anxiety isn’t new. It's called “cyberchondria,” which is the term used to describe the extreme anxiety caused by ...
Rick Hoffman recently posted a mirror selfie on Instagram, debuting a new, leaner look. He also shared the secret behind his body transformation. Check out his diet.
Today, a brief rundown of news from Ipsen and AstraZeneca, as well as updates from Sobi and the Food and Drug Administration that you may have missed.
Health Check: No more monkey business as European regulators signal approval of flagship Neuren drug
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has changed its stance and should approve Daybu … but CSL is not so lucky Echo IQ seeks $100 million while Recce ...
Thousands of bottles of a popular blood pressure medication have been recalled nationwide due to a potential manufacturing issue that may affect how well the drug works. According to the U.S. Food and ...
This system is designed as a research and educational tool to assist healthcare professionals and researchers. It does not replace clinical judgment, medical training, or professional expertise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results